PEDIATRIC MIGRAINE
Clinical trials for PEDIATRIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC MIGRAINE trials appear
Sign up with your email to follow new studies for PEDIATRIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with migraines: rimegepant enters final testing
Symptom relief Recruiting nowThis study tests whether rimegepant, a fast-dissolving tablet, can safely relieve migraine pain in children and adolescents aged 6 to 18. About 2,100 participants will receive either the drug or a placebo during a migraine attack. The main goal is to see if more kids become pain-…
Matched conditions: PEDIATRIC MIGRAINE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jul 02, 2026 03:00 UTC
-
Teens with migraine get a new Non-Drug option: group therapy with exercise and relaxation
Symptom relief Recruiting nowThis study tests a group therapy program for teens aged 13-17 with migraine. The program combines high-intensity interval training, progressive muscle relaxation, and education over 18 weeks. Researchers want to see if it reduces headache frequency, pain, and the need for medicat…
Matched conditions: PEDIATRIC MIGRAINE
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC